Researchers at Addenbrooke’s Hospital in Cambridgeshire are developing a new metabolic scanning system that is hoped to allow doctors to determine how well a cancer treatment is working, as soon as one day after treatment.
The scan shows whether a patient‘s treatment is working or whether the treatment needs changing, and therefore gives a better chance of success.
Patients receive an injection of pyruvate, which is created when glucose breaks down. This substance is marked with a non-radioactive form carbon to ensure molecules show up well under magnetic resonance imaging (MRI) (MRI) scans. The MRI can then show how quickly the pyruvate is breaking down in cancer cells, which is a measure of how active the cells are and therefore how effective a drug is at killing them.
Source: The Times